On page 678, it was noted that it has been reported that the acetylation of signal transducers and activators of transcription (STATs) is regulated by histone deacetylase (HDAC) inhibitors, based on reference 79 in the reference list. The authors would like to note that another paper (Mol. Cell. Biol. 31, 3029–3037; 2011) has reported that STAT1 signalling is not regulated by a phosphorylation–acetylation switch.
Rights and permissions
About this article
Cite this article
Falkenberg, K., Johnstone, R. Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders. Nat Rev Drug Discov 14, 219 (2015). https://doi.org/10.1038/nrd4579
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd4579
This article is cited by
-
TOB1 attenuates IRF3-directed antiviral responses by recruiting HDAC8 to specifically suppress IFN-β expression
Communications Biology (2022)
-
A novel dual HDAC and HSP90 inhibitor, MPT0G449, downregulates oncogenic pathways in human acute leukemia in vitro and in vivo
Oncogenesis (2021)
-
Tolerance of chronic HDACi treatment for neurological, visceral and lung Niemann-Pick Type C disease in mice
Scientific Reports (2018)
